Task Force Model

1316 Words3 Pages

Background/Problem Statement
According to the World Health Organization (WHO, 2011), smoking leads all other risk factors as the number one avoidable cause of death in the world; every year globally, cigarette smoking contribute to approximately six million deaths with more than 400,000 of them in America (WHO, 2011). The CDC (2008) also concluded by 2030 if this trend persists, each year more than eight million will die from tobacco related causes like COPD complications, as well as heart and lung cancer. Diseases and eventually deaths from tobacco induced issues are reduced for those who successfully quit smoking cigarettes (Anthonisen et al., 2005). People who do make a commitment to stop, benefit from reducing the risk of getting these …show more content…

This task force comprises of volunteer physicians of different specialties, nurses and other personnel with expert knowledge in prevention and evidence base healthcare. The task force was created in 1984 with current practicing clinicians for the purposes of reviewing, organizing and recommending evidence based management geared towards improving the health of our population USPSTF is authorized by Congress with mandates that the department of human services support their efforts, additionally in 2010 the Affordable care act made it mandatory that they also receive administrative support from the Agency for healthcare Research and Quality. Interestingly, the task force is independent from those two government bodies in the performance of their work (AHRQ, …show more content…

Data analysis The results will be represented as the relative risk or risk ratio (RR), that is (number of quitters in the treatment group/number randomized to the treatment group)/(number of quitters in the control group/number randomized to the control group). The Mantel-Haenszel test will be used if we find meta-analysis is needed (Lancaster, 2017)
In the event of loss to follow up For the purpose of evaluating the data appropriately, any documentation containing loss to follow-up will be further reviewed to rule out deaths. These will be removed and expressed separately. All others loss to follow up will be considered as failing the treatment and continuing to smoke. These numbers will be presented in a “loss to follow up” table format will also be included in the risk ratio calculation as denominators (Stead, Koilpillai, Fanshawe & Lancaster,

More about Task Force Model

Open Document